Yingle Li

Yingle Li

Auto-generated profile, based on publicly available information

Yingle Li

Institute for Stroke and Dementia Research (ISD), University Hospital, LMU Munich, Munich, Germany

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2021 in Neuropsychiatric Disease and Treatment
Verified
Journal Article
Open access
PDF file
HGHongquan Guo
Hongquan Guo
WXWei Xu
Wei Xu
XZXiaohao Zhang
Xiaohao Zhang
SZShuai Zhang
Shuai Zhang
ZDZheng Dai
Zheng Dai
XLXinfeng Liu
Xinfeng Liu
Background and Aims: A reliable predictive score system to identify the risk of symptomatic intracranial hemorrhage (sICH) after intravenous thrombolysis (IVT) in acute ischemic stroke patients is of great essence. We aimed to develop a nomogram for predicting the risk of sICH after IVT in Chinese patients. Methods: We recruited acute ischemic stroke patients who were treated with IVT from five advanced stroke centers in China from April 2014 to November 2020. sICH was diagnosed according to the European Cooperative Acute Stroke Study II (ECASS-II) definition. Multivariable logistic regression was performed to construct the best-fit nomogram. The discrimination and calibration of the nomogram were evaluated by the area under the receiver operating characteristic curve (AUC-ROC) and calibration plot. Results: A total of 1200 patients were enrolled, of whom 66 (5.5%) developed sICH. In the multivariate logistic regression model, atrial fibrillation (odds ratio [OR] 3.25; 95% confidence interval [CI], 1.89− 5.60; P < 0.001), baseline glucose level (OR, 1.13; 95% CI, 1.07− 1.20; P < 0.001), neutrophil to lymphocyte ratio (OR, 1.05; 95% CI, 1.01− 1.09; P = 0.024) and baseline National Institute of Health Stroke Scale (NIHSS) (OR, 1.07; 95% CI, 1.04− 1.10; P < 0.001) were independent predictors for sICH and were used to generate the nomogram. The nomogram demonstrated good discrimination as the AUC-ROC value was 0.788 (95% CI, 0.737– 0.840). The calibration plot revealed good calibration. Conclusion: The nomogram consisted of atrial fibrillation, baseline glucose level, neutrophil to lymphocyte ratio, and NIHSS score may predict the risk of sICH in Chinese acute ischemic stroke patients treated with IVT.

25 September 2026 in Science Advances
Verified
Journal Article
Closed access
LŽLuka Živković
Luka Živković
RBRoya Batool
Roya Batool
JLJulian Louma
Julian Louma
PAPaulo Alabarse
Paulo Alabarse
YLYingle Li
Yingle Li
Marios K GeorgakisMarios K Georgakis
Marios K Georgakis
Omics technologies enable deep profiling of human atherosclerosis but have mostly been applied in small studies lacking integration with other data modalities. AtherOMICS is a biobanking project linking multiomic atherosclerotic plaque phenotyping with blood biobanking, in vivo imaging, and clinical data. Here, we present the study protocol and show pilot results that demonstrate technical feasibility. Since August 2022, 246 patients scheduled to undergo carotid or femoral endarterectomy at Ludwig-Maximilians-Universität Klinikum (Munich, Germany), have been enrolled (median age, 73 years; 32% female), with recruitment ongoing. Plaques undergo systematic histological characterization of lipid core, calcification, intraplaque hemorrhage, fibrous cap, macrophages, and smooth muscle cells. Single-nucleus RNA sequencing ( n = 17) has confirmed macrophages as the dominant intraplaque cell type, whereas paired plaque and plasma affinity–based proteomics ( n = 88) quantified 2841 shared proteins showing low plaque-plasma correlation (median ρ = 0.10). Cross-modality image integration [histology, ex vivo magnetic resonance imaging (MRI), in vivo MRI, and computed tomography angiography] proved feasible. Together, AtherOMICS enables multimodal characterization of human atherosclerosis aiming for the discovery of athero-specific drug targets, molecular signatures of atheroprogression, and noninvasive biomarkers of plaque vulnerability.

12 April 2023 in Cerebrovascular Diseases
Verified
Journal Article
Closed access
PDF file
XCXiaoQing Cheng
XiaoQing Cheng
HLHongXia Li
HongXia Li
JLJia Liu
Jia Liu
CZChangSheng Zhou
ChangSheng Zhou
QLQuanHui Liu
QuanHui Liu
GLGuangMing Lu
GuangMing Lu
Introduction: Diabetes markedly affects the formation and development of intracranial atherosclerosis. The study was aimed at evaluating whether radiomics features can help distinguish plaques primarily associated with diabetes. Materials and Methods: We retrospectively analyzed patients who were admitted to our center because of acute ischemic stroke due to intracranial atherosclerosis between 2016 and 2022. Clinical data, blood biomarkers, conventional plaque features, and plaque radiomics features were collected for all patients. Odds ratios (ORs) with 95% confidence intervals (CIs) were determined from logistic regression models. The receiver operating characteristic (ROC) curve and area under the ROC curve (AUC) were used to describe diagnostic performance. The DeLong test was used to compare differences between models. Results: Overall, 157 patients (115 men; mean age, 58.7 ± 10.7 years) were enrolled. Multivariate logistic regression analysis showed that plaque length (OR: 1.17; 95% CI: 1.07–1.28) and area (OR: 1.13; 95% CI: 1.02–1.24) were independently associated with diabetes. On combining plaque length and area as a conventional model, the AUCs of the training and validation cohorts for identifying diabetes patients were 0.789 and 0.720, respectively. On combining radiomics features on T1WI and contrast-enhanced T1WI sequences, a better diagnostic value was obtained in the training and validation cohorts (AUC: 0.889 and 0.861). The DeLong test showed the model combining radiomics and conventional plaque features performed better than the conventional model in both cohorts (p < 0.05). Conclusions: The use of radiomics features of intracranial plaques on high-resolution magnetic resonance imaging can effectively distinguish culprit plaques with diabetes as the primary pathological cause, which will provide new avenues of research into plaque formation and precise treatment.

18 June 2025 in medRxiv
Verified
Preprint
Open access
PDF file
LŽLuka Živković
Luka Živković
RBRoya Batool
Roya Batool
JLJulian Louma
Julian Louma
PAPaulo Alabarse
Paulo Alabarse
YLYingle Li
Yingle Li
Marios K GeorgakisMarios K Georgakis
Marios K Georgakis
Omics technologies enable deep profiling of human atherosclerosis, but have mostly been applied in small studies lacking integration with other data modalities. AtherOMICS is a biobanking project linking multi-omic atherosclerotic plaque phenotyping with blood biobanking, in vivo imaging, and clinical data. Since August 2022, 246 patients scheduled to undergo carotid or femoral endarterectomy at LMU Klinikum (Munich, Germany), have been enrolled (median age 73 years, 32% female). Plaques undergo systematic histological characterization of lipid core, calcification, intraplaque hemorrhage, fibrous cap, macrophages, and smooth muscle cells. Single-nuclei RNAseq (n=17) has highlighted macrophages as the dominant intraplaque cell type, whereas paired plaque and plasma affinity-based proteomics (n=88) quantified 2,841 shared proteins showing low plaque-plasma correlation (median ρ=0.10). Cross-modality image integration (histology, ex vivo MRI, in vivo MRI, CTA) proved feasible. Taken together, AtherOMICS enables multimodal characterization of human atherosclerosis aiming for the discovery of athero-specific drug targets, molecular signatures of atheroprogression, and non-invasive biomarkers of plaque vulnerability.

29 September 2026 in medRxiv
Verified
Preprint
Open access
PDF file
SMStefan Mayrhofer
Stefan Mayrhofer
LŽLuka Živković
Luka Živković
YLYingle Li
Yingle Li
RBRoya Batool
Roya Batool
JLJulian Louma
Julian Louma
Marios K GeorgakisMarios K Georgakis
Marios K Georgakis
Background and Aims: Quantifying arterial inflammation can augment risk stratification and drug development in atherosclerosis. While perivascular adipose tissue (PVAT) density, captured as fat attenuation index (FAI) on CT angiography (CTA), is an emerging biomarker of coronary inflammation, it remains unclear whether this concept extends to carotid atherosclerosis. Methods: Using routine CTA data from hospital-based stroke cohorts, we developed a pipeline to quantify attenuation metrics of PVAT surrounding the distal common and proximal internal carotid arteries. We compared PVAT metrics between culprit and contralateral non-culprit plaques in patients with symptomatic carotid atherosclerosis and between culprit plaques and control carotid segments from patients without symptomatic atherosclerosis. In patients undergoing carotid endarterectomy, we assessed associations of CTA-derived PVAT metrics with histological and proteomic markers of plaque inflammation and stability. Results: Across 107 patients with symptomatic carotid atherosclerosis (75.5±8.7 years; 63% men), PVAT attenuation metrics did not show significant differences between culprit and contralateral non-culprit lesions (all p>0.2). We also found no evidence for higher PVAT attenuation in culprit lesions, when compared to arteries of patients without symptomatic atherosclerosis. In 82 patients undergoing endarterectomy, pre-operative CTA-derived metrics of PVAT attenuation showed no significant correlations with CD68+ macrophage areas in excised plaques (r -0.11 to 0.07, all p>0.3). Similarly, no PVAT attenuation metrics were associated with thinner fibrous cap or higher plaque levels of pro-inflammatory cytokines (IL-6, TNF). Conclusions: In contrast to coronary atherosclerosis, carotid PVAT attenuation was not associated with symptomatic culprit lesions or histological and molecular markers of plaque inflammation and vulnerability. Structured Graphical Key Question: Can perivascular adipose tissue (PVAT) attenuation on CT, proposed as a marker of coronary artery inflammation, also capture atherosclerotic plaque inflammation and vulnerability in the carotid arteries? Key Finding: In 107 patients with carotid atherosclerosis-associated stroke, PVAT attenuation did not differ between culprit and contralateral non-culprit lesions and was not associated with histopathological or molecular markers of plaque inflammation and vulnerability. Take-home Message: PVAT attenuation did not capture local carotid plaque inflammation or vulnerability in this cohort, questioning the transferability of this CT-based marker from coronary to carotid atherosclerosis.

29 October 2026 in medRxiv
Verified
Preprint
Open access
PDF file
YLYingle Li
Yingle Li
LZLuka Zivkovic
Luka Zivkovic
RBRoya Batool
Roya Batool
AMAbdalla Marei
Abdalla Marei
PRPaul Reidler
Paul Reidler
Marios K GeorgakisMarios K Georgakis
Marios K Georgakis
Background: Carotid plaque vulnerability features may provide prognostic information beyond luminal stenosis, but the value of quantitative plaque composition on CTA remains unclear. Objectives: We investigated whether plaque composition analysis in routine CTA in patients with ischemic stroke or TIA can identify high-risk plaques across etiologies, particularly among strokes of undetermined etiology and predict residual vascular risk. Methods: We analyzed carotid CTAs from 314 patients with acute ischemic stroke or TIA. CTA-derived plaque composition was quantified using commercially available software and compared between ipsilateral and contralateral plaques across etiology groups. Associations of plaque characteristics with subsequent vascular events were assessed using Cox regression models. Results: Among patients with ischemic events of undetermined etiology, ipsilateral plaques showed significant enrichment for greater LRNC volume (ratio, 1.97; 95% CI, 1.22–3.18), an association that persisted after adjustment for wall volume (ratio, 1.51; 95% CI, 1.15–1.99). During a median 3-year follow-up, larger LRNC volume was associated with subsequent vascular events in patients with ischemic stroke of undetermined etiology (HR, 1.96; 95% CI, 1.12–3.43), as were calcification, noncalcified matrix, and total wall volumes. Associations for individual plaque components attenuated after adjustment for wall volume. Conclusions: CTA-derived LRNC is enriched in carotid plaques ipsilateral to ischemic events of undetermined etiology and is associated with future vascular risk. Quantitative CTA-based plaque assessment may provide complementary information for etiologic evaluation and vascular risk stratification.